Technical / White Paper

Psychedelics and Entactogens: Challenges Associated with Schedule I Therapeutic Development

Format: PDF file | Document type: Technical / White Paper | Promoted Content

This Technical / White Paper has been written by Altasciences , and any views and opinions expressed do not necessarily reflect those of www.outsourcing-pharma.com

Psychedelics and Entactogens: Challenges Associated with Schedule I Therapeutic Development

Under the Controlled Substances Act (CSA) in the United States, drugs that have the potential to be abused are scheduled into one of five Classes or Schedules (CI-V) as controlled substances. The scheduling method makes a distinction for drugs that have abuse potential and are not approved for medical use (i.e., Schedule I) versus drugs that are approved for medical use.

Related resources from Altasciences

Show more

Supplier info centre